GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Daito Pharmaceutical Co Ltd (TSE:4577) » Definitions » Cyclically Adjusted Revenue per Share

Daito Pharmaceutical Co (TSE:4577) Cyclically Adjusted Revenue per Share : 円3,186.12 (As of Nov. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Daito Pharmaceutical Co Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Daito Pharmaceutical Co's adjusted revenue per share for the three months ended in Nov. 2024 was 円778.526. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is 円3,186.12 for the trailing ten years ended in Nov. 2024.

During the past 12 months, Daito Pharmaceutical Co's average Cyclically Adjusted Revenue Growth Rate was 4.00% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 3.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Daito Pharmaceutical Co was 3.30% per year. The lowest was 2.80% per year. And the median was 3.05% per year.

As of today (2025-05-24), Daito Pharmaceutical Co's current stock price is 円2057.00. Daito Pharmaceutical Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Nov. 2024 was 円3,186.12. Daito Pharmaceutical Co's Cyclically Adjusted PS Ratio of today is 0.65.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Daito Pharmaceutical Co was 1.48. The lowest was 0.60. And the median was 0.83.


Daito Pharmaceutical Co Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Daito Pharmaceutical Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daito Pharmaceutical Co Cyclically Adjusted Revenue per Share Chart

Daito Pharmaceutical Co Annual Data
Trend May15 May16 May17 May18 May19 May20 May21 May22 May23 May24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,759.85 2,819.48 2,904.88 3,002.49 3,111.74

Daito Pharmaceutical Co Quarterly Data
May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,082.06 3,111.74 3,157.82 3,186.12 -

Competitive Comparison of Daito Pharmaceutical Co's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Daito Pharmaceutical Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Daito Pharmaceutical Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Daito Pharmaceutical Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Daito Pharmaceutical Co's Cyclically Adjusted PS Ratio falls into.


;
;

Daito Pharmaceutical Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Daito Pharmaceutical Co's adjusted Revenue per Share data for the three months ended in Nov. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Nov. 2024 (Change)*Current CPI (Nov. 2024)
=778.526/110.0000*110.0000
=778.526

Current CPI (Nov. 2024) = 110.0000.

Daito Pharmaceutical Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201502 578.383 97.600 651.866
201505 683.626 98.700 761.893
201508 634.488 98.400 709.285
201511 696.272 98.100 780.733
201602 631.190 97.800 709.927
201605 677.146 98.200 758.514
201608 661.923 97.900 743.734
201611 734.436 98.600 819.351
201702 631.986 98.100 708.649
201705 730.193 98.600 814.617
201708 703.425 98.500 785.551
201711 782.687 99.100 868.775
201802 667.082 99.500 737.478
201805 744.272 99.300 824.470
201808 707.547 99.800 779.861
201811 756.109 100.000 831.720
201902 745.093 99.700 822.069
201905 779.683 100.000 857.651
201908 847.074 100.000 931.781
201911 832.905 100.500 911.637
202002 785.160 100.300 861.093
202005 732.149 100.100 804.559
202008 924.754 100.100 1,016.213
202011 817.566 99.500 903.842
202102 782.355 99.800 862.315
202105 720.601 99.400 797.446
202108 778.706 99.700 859.154
202111 704.927 100.100 774.645
202202 719.881 100.700 786.365
202205 628.682 101.800 679.322
202208 760.356 102.700 814.403
202211 714.484 103.900 756.432
202302 708.916 104.000 749.815
202305 666.182 105.100 697.241
202308 770.662 105.900 800.499
202311 754.999 106.900 776.893
202402 672.316 106.900 691.813
202405 791.114 108.100 805.019
202408 829.224 109.100 836.065
202411 778.526 110.000 778.526

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Daito Pharmaceutical Co  (TSE:4577) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Daito Pharmaceutical Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=2057.00/3186.12
=0.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Daito Pharmaceutical Co was 1.48. The lowest was 0.60. And the median was 0.83.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Daito Pharmaceutical Co Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Daito Pharmaceutical Co's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Daito Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
326 Yokamachi, Toyama, JPN, 939-8567
Daito Pharmaceutical Co Ltd is engaged in the research and development of pharmaceutical products. The company also undertakes contract manufacturing.

Daito Pharmaceutical Co Headlines

No Headlines